Charlène van der Zijden

7PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Social epidemiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 18, 2026
Total Neoadjuvant Treatment for Esophageal Adenocarcinoma With Oligometastases: TNT-OES-1 Trial.

|Feb 17, 2026
Survival after pathological complete response following neoadjuvant chemotherapy versus chemoradiotherapy for oesophageal squamous cell carcinoma.

Jun Okui, Satoru Matsuda, Kengo Nagashima

|Jan 07, 2026
Conditional recurrence-free survival after curative esophagectomy: individual patient data analysis of 11 trials.

Jun Okui, Satoru Matsuda, Kengo Nagashima

|Aug 25, 2025
Recurrence-free Survival as a Surrogate Endpoint for Overall Survival in Resectable Esophageal Cancer: Integrated Analysis of Individual Patient Data From Phase III Trials.

Jun Okui, Satoru Matsuda, Kengo Nagashima

|Jun 26, 2025
Evaluation of pathological complete response as a surrogate endpoint for overall survival in resectable oesophageal cancer: integrated analysis of individual patient data from phase III trials.

Jun Okui, Kengo Nagashima, Satoru Matsuda

|Apr 13, 2024
Perioperative Chemotherapy for Gastro-Esophageal or Gastric Cancer: Anthracyclin Triplets versus FLOT.

Julie F M Geerts, Charlène J van der Zijden, Pieter C van der Sluis

Pageof 2

Frequent Collaborators

4 joint publications

Jun Okui

4 joint publications

Kengo Nagashima

4 joint publications

Satoru Matsuda

4 joint publications

Fredrik Klevebro